Correlation Between Pfizer and Algoma Central

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and Algoma Central at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Algoma Central into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc CDR and Algoma Central, you can compare the effects of market volatilities on Pfizer and Algoma Central and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Algoma Central. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Algoma Central.

Diversification Opportunities for Pfizer and Algoma Central

-0.58
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Pfizer and Algoma is -0.58. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc CDR and Algoma Central in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Algoma Central and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc CDR are associated (or correlated) with Algoma Central. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Algoma Central has no effect on the direction of Pfizer i.e., Pfizer and Algoma Central go up and down completely randomly.

Pair Corralation between Pfizer and Algoma Central

Assuming the 90 days trading horizon Pfizer Inc CDR is expected to under-perform the Algoma Central. In addition to that, Pfizer is 1.29 times more volatile than Algoma Central. It trades about -0.13 of its total potential returns per unit of risk. Algoma Central is currently generating about 0.08 per unit of volatility. If you would invest  1,408  in Algoma Central on September 12, 2024 and sell it today you would earn a total of  75.00  from holding Algoma Central or generate 5.33% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Pfizer Inc CDR  vs.  Algoma Central

 Performance 
       Timeline  
Pfizer Inc CDR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc CDR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.
Algoma Central 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Algoma Central are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy fundamental indicators, Algoma Central is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Pfizer and Algoma Central Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and Algoma Central

The main advantage of trading using opposite Pfizer and Algoma Central positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Algoma Central can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Algoma Central will offset losses from the drop in Algoma Central's long position.
The idea behind Pfizer Inc CDR and Algoma Central pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Other Complementary Tools

Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios